HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antibiotic-coated hemodialysis catheters for the prevention of vascular catheter-related infections: a prospective, randomized study.

AbstractPURPOSE:
To determine the efficacy of minocycline-rifampin-coated hemodialysis catheters in reducing catheter-related infections in patients requiring hemodialysis for acute renal failure.
METHODS:
Between May 2000 and March 2002, 66 patients were randomly assigned to receive a minocycline-rifampin-impregnated central venous catheter and 64 were randomly assigned to receive an unimpregnated catheter. Patients were followed prospectively until the catheter was removed. Catheter-related infection was determined through quantitative catheter cultures, quantitative blood cultures, or both.
RESULTS:
Both groups of patients were similar in age, sex, underlying disease, type of dialysis (continuous vs. intermittent), neutropenia during catheterization and its duration, catheter insertion difficulties, and administration of blood products or medication. The mean (+/- SD) catheter dwell time was the same in both groups (8 +/- 6 days, P = 0.7). There were seven catheter-related infections (11%), all associated with the use of unimpregnated catheters. Kaplan-Meier estimates for the risk of catheter-related infection showed that coated catheters were less likely to be associated with infection (P = 0.006).
CONCLUSION:
The use of polyurethane hemodialysis catheters impregnated with minocycline and rifampin decreases the risk of catheter-related infection in patients with acute renal failure.
AuthorsIoannis Chatzinikolaou, Kevin Finkel, Hend Hanna, Maha Boktour, John Foringer, Tam Ho, Issam Raad
JournalThe American journal of medicine (Am J Med) Vol. 115 Issue 5 Pg. 352-7 (Oct 01 2003) ISSN: 0002-9343 [Print] United States
PMID14553869 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Bacterial Agents
  • Antibiotics, Antitubercular
  • Polyurethanes
  • Minocycline
  • Rifampin
Topics
  • Acute Kidney Injury (therapy)
  • Anti-Bacterial Agents (administration & dosage, therapeutic use)
  • Antibiotics, Antitubercular (administration & dosage, therapeutic use)
  • Catheterization, Central Venous (adverse effects, instrumentation)
  • Drug Therapy, Combination (administration & dosage, therapeutic use)
  • Female
  • Humans
  • Male
  • Methicillin Resistance
  • Middle Aged
  • Minocycline (administration & dosage, therapeutic use)
  • Polyurethanes
  • Prospective Studies
  • Renal Dialysis (instrumentation)
  • Rifampin (administration & dosage, therapeutic use)
  • Staphylococcal Infections (prevention & control)
  • Staphylococcus aureus (drug effects)
  • Staphylococcus epidermidis
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: